U.S. Electric Utilities Stock News

NYSE:GRDN
NYSE:GRDNHealthcare

Is It Too Late To Consider Guardian Pharmacy Services (GRDN) After Its 45% One Year Rally?

If you are wondering whether Guardian Pharmacy Services at US$37.37 still offers value after a strong run, the next sections will walk through what the current price could be implying. The stock has slipped 0.5% over the last 7 days and 1.6% over the last 30 days, yet it is still up 26.5% year to date and 44.9% over the past year, which may have shifted how some investors view its risk and reward trade off. Recent attention on Guardian Pharmacy Services has largely centered on its role...
NasdaqGS:MCHB
NasdaqGS:MCHBBanks

Assessing Mechanics Bancorp (MCHB) Valuation After Recent Share Price Moves

Why Mechanics Bancorp (MCHB) is on investors’ radar Mechanics Bancorp (MCHB) has attracted fresh attention after recent share price moves, with the stock up about 1% over the past day but slightly lower over the past week and past 3 months. See our latest analysis for Mechanics Bancorp. While the share price has eased over the past week and quarter, the 1-year total shareholder return of 70.51% and 5-year total shareholder return of 166.71% indicate strong momentum over a longer horizon...
NYSE:DQ
NYSE:DQSemiconductor

Is Daqo New Energy (DQ) Pricing Look Attractive After Recent Share Price Slide

If you are wondering whether Daqo New Energy's current share price reflects its true worth, it helps to start with how the market has been treating the stock lately. The shares last closed at US$19.14, with returns of a 16.7% decline over 7 days, a 9.3% decline over 30 days, and a 35.5% decline year to date, contrasted with a 48.5% gain over the past year and larger declines of 57.2% and 74.4% over 3 and 5 years. These moves have played out against a backdrop of ongoing interest in the solar...
NYSE:BW
NYSE:BWElectrical

Babcock And Wilcox Faces Contract Scrutiny And Governance Risks For Investors

Short-seller report challenges the legitimacy of Babcock & Wilcox Enterprises' purported $2.4b contract and raises concerns about undisclosed related-party links. Securities fraud class action lawsuits have been filed, alleging failures in disclosure and questioning the integrity of the company’s contract reporting. These governance and disclosure issues are drawing attention to the risks around large power generation deals and potential impact on shareholder confidence. Babcock & Wilcox...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Acadia R&D Chief Plans Retirement As Company Stresses Pipeline Continuity

Acadia Pharmaceuticals (NasdaqGS:ACAD) announced the planned retirement of its Head of Research and Development, Dr. Elizabeth H.Z. Thompson. Dr. Thompson is expected to transition from her current role and remain with the company as a consultant through at least the end of 2026. Her consulting role is intended to support continuity around a key Phase 2 clinical readout in Alzheimer's disease psychosis and early Phase 3 planning. Acadia focuses on central nervous system conditions, where...
NYSE:BIPC
NYSE:BIPCGas Utilities

Brookfield Infrastructure (BIPC) Is Down 8.5% After Mixed Q1 Results and Capital Recycling Update – What's Changed

Brookfield Infrastructure Corporation reported first-quarter 2026 results showing sales of US$884 million versus US$929 million a year earlier, and a net loss of US$112 million compared with prior-year net income of US$389 million, while affirming a quarterly dividend of US$0.4550 per share payable on June 30, 2026. Beneath the weaker accounting earnings, management highlighted a 10% increase in funds from operations, progress toward about US$1 billion of capital recycling, and a 6% dividend...
NYSE:GENI
NYSE:GENIHospitality

Is It Time To Revisit Genius Sports (GENI) After This Year’s Sharp Share Price Slide?

If you are wondering whether Genius Sports at US$4.35 is a bargain or a value trap, the starting point is to understand what the current share price is really pricing in. The stock has seen a 2.7% decline over the last week, a 4.6% decline over the last month and a 59.6% decline year to date, while the 1 year return is a 60.6% loss and the 5 year return is a 76.8% loss, with only the 3 year period showing an 8.2% gain. These moves sit against a backdrop of ongoing attention on sports data,...
NYSE:ARMK
NYSE:ARMKHospitality

Is It Too Late To Consider Aramark (ARMK) After Strong Recent Share Price Gains?

If you are wondering whether Aramark’s current share price reflects its true value, the next sections walk through what the numbers actually say about the stock. Aramark shares last closed at US$44.95, with returns of 5.6% over 30 days, 22.9% year to date and 35.2% over 1 year, which has many investors reassessing both its potential and its risks. Over the past year Aramark has been in the spotlight as investors have tracked its performance and repositioned their expectations for the...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Loss Of US$2.8b Keeps Bearish Narratives In Focus

Moderna (MRNA) opened 2026 with Q1 results that continue the recent trend of revenue and losses sitting side by side, with trailing 12 month revenue at US$1.9 billion and a basic EPS loss of US$7.25 per share tied to a net loss of US$2.8 billion. Over recent quarters, the company has seen quarterly revenue move between US$108 million and US$1.9 billion with basic EPS ranging from a small profit of US$0.03 per share in Q3 2024 to losses of more than US$2.50 per share in several 2025 quarters,...
NYSE:PIPR
NYSE:PIPRCapital Markets

Piper Sandler (PIPR) Margin Expansion Challenges Cautious Earnings Narratives Heading Into Q1 2026

Piper Sandler Companies (PIPR) has entered Q1 2026 with trailing 12 month revenue of about US$1.9b and basic EPS of US$4.22. This is alongside year over year earnings growth of 55.3% and revenue growth of 9.8%. Over the past reported quarters, total revenue has moved from US$484.1 million in Q4 2024 to US$666.1 million in Q4 2025, while quarterly basic EPS has ranged from US$0.55 in Q3 2024 to US$1.69 in Q4 2025. Taken together, these figures present a picture of improving profitability and...
NYSE:TYL
NYSE:TYLSoftware

Tyler Technologies Leans On FTR Deal To Accelerate Cloud And AI Shift

Tyler Technologies (NYSE:TYL) has completed its third largest acquisition, For The Record, adding court recording and transcription technology to its portfolio. The company has updated revenue guidance to reflect FTR and is leaning on the deal to support its shift toward cloud and AI-enabled solutions. Tyler is advancing its cloud migration plan, targeting nearly all new public safety clients and 80% of on premise customers to be in the cloud by 2030. For Tyler Technologies, a long time...
NasdaqGS:DORM
NasdaqGS:DORMAuto Components

Is It Time To Reassess Dorman Products (DORM) After Recent Auto Components Sector Focus?

If you are wondering whether Dorman Products is attractively priced or looking stretched at around US$112.88, this article walks through the numbers that matter for valuation. The stock price sits at US$112.88, with returns of 1.5% over the last week, 11.9% over the last month, a 9.0% decline year to date, and a 2.1% decline over the last year. These returns are set against 27.7% and 8.1% over the past 3 and 5 years. Recent news coverage has focused on Dorman Products in the context of...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Syndax Pharmaceuticals (SNDX) Narrows Q1 Loss To US$42.7 Million Challenging Bearish Narratives

Syndax Pharmaceuticals (SNDX) opened Q1 2026 with total revenue of US$64.9 million and a basic EPS loss of US$0.48, alongside a net loss of US$42.7 million. This puts fresh numbers around how the business is scaling its commercial model while still running in the red. Over recent quarters the company has reported revenue of US$7.7 million in Q4 2024, US$20.0 million in Q1 2025, and US$68.7 million in Q4 2025, with basic EPS losses of US$1.10, US$0.98, and US$0.78 over those same periods as it...
NYSE:UMH
NYSE:UMHResidential REITs

UMH Properties (UMH) Q1 FFO Of US$76 Million Tests Bearish Funding Narratives

UMH Properties (UMH) opened 2026 with Q1 revenue of US$65.8 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$265.9 million and EPS of US$0.10 that sit against earnings growth forecasts of about 7.9% per year. Over recent periods, total revenue has moved from US$240.2 million in the trailing twelve months to Q4 2024 up to US$265.9 million in the latest trailing period, while quarterly basic EPS has ranged between a small loss of roughly US$0.01 in early 2025 and...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

Palisades Backs SkyWater Ahead Of IonQ Deal As Valuation Questions Linger

Palisades Investment Partners has taken a new stake in SkyWater Technology (NasdaqCM:SKYT). The position is reportedly linked to expectations around SkyWater's planned acquisition by IonQ, targeted for completion later in 2026. The deal is expected to involve a mix of cash and stock, which may be relevant for existing and prospective shareholders. For you as an investor, the key point is that an institutional player is committing fresh capital to a company already in the middle of an...
NYSE:LW
NYSE:LWFood

Starboard Presses Lamb Weston For Clearer Targets And Cost Discipline

Starboard Value, a major shareholder in Lamb Weston Holdings (NYSE:LW), has publicly urged the company to reset its strategy. The activist investor is calling for an investor day, clearer earnings targets, and tighter cost control. Starboard argues that these steps are needed to rebuild management credibility and sharpen execution. Lamb Weston is a large frozen potato products supplier, with customers that range from global restaurant chains to retail grocery channels. The company sits at...
BATS:CBOE
BATS:CBOECapital Markets

Cboe Global Markets (CBOE) Margin Strength And 43.9% EPS Growth Test Slower Growth Narrative

Cboe Global Markets (CBOE) just opened Q1 2026 earnings season with a solid set of headline figures, anchored by Q4 2025 revenue of US$1.2b and basic EPS of US$2.98, alongside trailing twelve month revenue of US$4.7b and EPS of US$10.46 that reflect its latest run rate. Over recent quarters the company has seen revenue move from US$1.11b in Q4 2024 to US$1.20b in Q4 2025, while quarterly EPS shifted from US$1.87 to US$2.98. This sets up a story where higher earnings and a 23.2% trailing net...
NYSE:LAD
NYSE:LADSpecialty Retail

Is Lithia Motors (LAD) Pricing Look Attractive After Recent Share Price Rebound

If you are wondering whether Lithia Motors at around US$290.90 is a bargain or a value trap, a good starting point is understanding how its current share price compares to different measures of fair value. The stock has recently seen a 5.8% move over 7 days and a 16.0% change over 30 days, while the return year to date is a 12.5% decline and the 1 year return is a 1.1% decline, with a 37.5% gain over 3 years and a 20.9% decline over 5 years. Recent news coverage has focused on Lithia Motors...
NasdaqGS:FWON.K
NasdaqGS:FWON.KEntertainment

Formula One Group’s Pacsun Tie Up Extends Fashion Story For FWON.K

Formula One Group and Pacsun announced an official Formula 1 Miami Grand Prix 2026 Collection, expanding F1 branded fashion into the U.S. retail market. The collection focuses on race inspired designs and is tied to the Miami Grand Prix weekend, targeting Gen Z and millennial shoppers. The move reflects Formula One Group's push to extend its brand into lifestyle and streetwear beyond the core motorsports audience. For investors tracking NasdaqGS:FWON.K, this Pacsun collaboration adds...
NYSE:ATMU
NYSE:ATMUMachinery

Atmus Filtration Technologies (ATMU) Margin Strength Supports Bullish Narratives Heading Into Q1 2026

Atmus Filtration Technologies (ATMU) has just put fresh numbers on the board for Q1 2026, coming off a recent quarter where Q4 2025 revenue was US$446.6 million and basic EPS was US$0.59, backed by trailing 12 month EPS of US$2.52 and net income of US$207.4 million. Over the past year, the company has seen revenue move from US$406.7 million in Q4 2024 to US$446.6 million in Q4 2025, while quarterly EPS shifted from US$0.48 to US$0.59, setting up this latest print against a backdrop of higher...
NYSE:EL
NYSE:ELPersonal Products

Estée Lauder (EL) Returns To Quarterly Profit As EPS Recovery Tests Bearish Narratives

Estée Lauder Companies (EL) has put fresh numbers on the table for its latest quarter, with Q2 2026 revenue of US$4.2b and basic EPS of US$0.45, set against a trailing twelve month picture that still shows a basic EPS loss of US$0.49 on revenue of US$14.7b. Over recent quarters, the company has seen revenue move between US$3.4b and US$4.0b in fiscal 2025, before reaching US$3.5b in Q1 2026 and US$4.2b in Q2 2026. Basic EPS has ranged from losses of around US$1.64 per share to a recent profit...
NYSE:AOS
NYSE:AOSBuilding

A. O. Smith Cuts 2026 Outlook As China Weakness And U.S. Issues Bite

A. O. Smith (NYSE:AOS) reported Q1 2026 results that missed expectations, citing weak demand in China and production issues at its Ashland City facility. The company lowered its full-year 2026 guidance for both sales and earnings, reflecting softer performance and operational challenges. Management outlined a targeted restructuring of the North America water treatment business and plans for price increases to address higher input costs. A. O. Smith, a manufacturer of water heaters and water...
NYSE:DBRG
NYSE:DBRGCapital Markets

A Look At DigitalBridge Group (DBRG) Valuation After Strong 1-Year Returns And Mixed Multiple Signals

DigitalBridge Group (DBRG) continues to draw attention as investors weigh its role in digital infrastructure against recent share performance. The stock last closed at US$15.55 and has a market value of about US$2.9b. See our latest analysis for DigitalBridge Group. While the recent 1-day and 7-day share price returns are slightly negative, DigitalBridge Group’s 1-year total shareholder return of 69.55% contrasts with a 5-year total shareholder return decline of 43.82%. This suggests momentum...
NYSE:CLX
NYSE:CLXHousehold Products

Clorox (CLX) Q3 2026 Net Margin Expansion Tests Bullish ERP Efficiency Narrative

Q3 2026 earnings snapshot and how the story stacks up Clorox (CLX) has just posted Q3 2026 results with revenue of US$1,670 million and basic EPS of US$1.54, setting the tone for how investors read its latest trading update. Over the past few quarters the company has seen revenue move in a tight band around US$1,670 million while basic EPS has ranged from US$0.65 in Q1 2026 to US$2.70 in Q4 2025, giving you a clear view of how earnings swing through the year. With trailing twelve month...